Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fiber-Stat is a concentrated liquid fiber supplement, primarily composed of polydextrose, designed to provide a high dose of soluble fiber in a low-volume dose. In the context of clinical research at Virginia Commonwealth University, it has been evaluated for its potential therapeutic role in women with polycystic ovary syndrome (PCOS). The supplement is hypothesized to improve metabolic parameters, such as insulin sensitivity, and restore regular ovulation by slowing the absorption of dietary carbohydrates and modulating the gut environment. As a prebiotic, it may also influence the gut microbiota, which is increasingly recognized as a factor in the pathophysiology of PCOS and associated metabolic disturbances.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fiber-Stat.